ON DEMAND – Lung cancer: Key advances and clinical impacts in 2021

9 Nov 2021

This week an expert panel reviewed key trial data lung cancer in 2021 focussing on potential clinical impacts for Australian oncology practice.

If you didn’t catch the webinar, you can now watch on demand here:

Chaired by Professor Nick Pavlakis. Senior Staff Specialist, Department of Medical Oncology, Royal North Shore Hospital, Sydney; Board Chair, TOGA; President, Australasian Lung Cancer Trials Group; Past President, COSA.


Professor Chris Karapetis. Head of Medical Oncology, Flinders Medical Centre; Network Director of Cancer Services, Southern Area LHN, Adelaide; Director of Clinical Research in Medical Oncology, Flinders Medical Centre and Flinders Centre for Innovation in Cancer, SA.

Professor Stephen Clarke. Professor of Medicine, University of Sydney, NSW.

Associate Professor Emily Stone. UNSW, St Vincent’s Clinical School; St Vincent’s Hospital Sydney, NSW.

This event is created independently by the limbic in collaboration with the host and presenters. All studies are selected by the presenters, and all views expressed are those of the host and presenters only. Thank you to BMS for providing the non-restrictive educational sponsorship that made this program possible.

Already a member?

Login to keep reading.

Email me a login link